H&R WASAG: Sales and profits reached record level
In the second quarter, sales grew to EUR203.3 million (Q2 2005: EUR157.4 million). This corresponds to growth of 29% compared with the same quarter of the previous year or 3% compared with the preceding, first quarter of 2006. EBITDA operating profits rose in the second quarter to EUR28.8 million (Q2 2005: EUR9.6 million) and were, as a consequence, 30% above the result of the first quarter. Compared with the second quarter of the previous year, the operating result tripled.
On a cumulative basis, sales in the first half year reached EUR401.6 million (H1 2005: EUR293.8 million). At EUR50.9 million, the operating result more than doubled compared with the level of the same period of the previous year (H1 2005: EUR19.4 million). During the course of the last six months, pre-tax earnings rose to EUR37.7 million (H1 2005: EUR8.0 million) and, as a consequence, more than quadrupled compared with the comparable period of the previous year.
In the second quarter, H&R WASAG also benefited from rising demand in all three divisional areas of the Group. Above all, both specialty refineries in the Chemical-Pharmaceutical Raw Materials Division are currently operating at full capacity utilization and registered a marked increase in sales. However, both the Explosives and Plastics divisions have also generated rising turnover.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.